HONG KONG (Reuters) – Shanghai Pharmaceuticals Holding Co has bid for Cardinal Health Inc’s China business as the U.S. company looks to sell ahead of China’s planned drug distribution reform. Shanghai Pharma submitted two non-binding bids to buy …
( read original story …)